PRP Pure has introduced two new injectable treatments, EXOBIOFILLER and EXOPRP, expanding its regenerative aesthetics portfolio. Officially launching at the Clinical Cosmetic Regenerative Congress (CCR) 2026, both products combine platelet-rich plasma (PRP) with patient-derived regenerative components to support tissue rejuvenation and aesthetic treatments.
Get the latest in Medical Aesthetics in our weekly ValuraNova Pulse. Sign up now.
EXOBIOFILLER is designed as an autologous alternative to conventional dermal fillers, while EXOPRP combines PRP with autologous injectable exosomes for regenerative and aesthetic applications.
“This innovative procedure harnesses the power of a modified autologous exosome solution to stimulate natural skin rejuvenation while delivering subtle, filler-like volume,” said George Brankov, CEO of PRP Pure. “By using the patient’s own regenerative cells, the treatment enhances skin quality, improves texture and elasticity.”
Read the full story here.
